Tirzepatide 30mg
GLP-2TIRZ 30mg – Premium Research Peptide
GLP-2TIRZ is a first-in-class dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its unique dual incretin mechanism has made it a major focus of research into glucose regulation, weight management, and metabolic health. This 30mg vial provides a larger format for laboratories conducting extended or high-dosage studies.
Key Benefits for Research
- High-purity 30mg vial of GLP-2TIRZ for advanced research needs
- Dual GIP/GLP-1 receptor activity for metabolic studies
- Studied for glucose regulation, appetite control, and weight loss
- Manufactured in the USA with rigorous quality standards
About Tirzepatide
GLP-2TIRZ acts on two key incretin pathways, enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and regulating appetite. Research continues to explore its applications for type 2 diabetes, obesity, and metabolic syndrome, with promising results in preclinical and clinical studies.
Why Choose Our GLP-2TIRZ 30mg?
Our GLP-2TIRZ 30mg is produced using advanced peptide synthesis to guarantee exceptional purity, stability, and reproducibility. Each vial undergoes strict laboratory testing, making it a dependable choice for metabolic and endocrine research requiring larger doses.
Usage & Storage
- For laboratory research use only
- Store at -20°C for long-term stability
- Reconstitute with sterile solution prior to use
Product Details
- CAS Number: 2023788-19-2
- Molecular Formula: C225H348N48O68
- Molecular Weight: ~4,814 g/mol
- Appearance: White lyophilized powder







Reviews
There are no reviews yet.